초록 ▼

The present invention provides a medical device, and methods of preparing and using a medical device. The medical device has a surface including a biologically active agent therein. The methods are particularly useful for preparing, for example, coated stents having a biologically active agent withi

The present invention provides a medical device, and methods of preparing and using a medical device. The medical device has a surface including a biologically active agent therein. The methods are particularly useful for preparing, for example, coated stents having a biologically active agent within the coating.

대표청구항 ▼

What is claimed is: 1. A method of preparing a medical device comprising: providing a device comprising a porous exposed surface, wherein at least a portion of the pores contain a biologically active agent; and heating at least the porous exposed surface at a temperature of about 30° C. to abo

What is claimed is: 1. A method of preparing a medical device comprising: providing a device comprising a porous exposed surface, wherein at least a portion of the pores contain a biologically active agent; and heating at least the porous exposed surface at a temperature of about 30° C. to about 100° C. to at least partially collapse the porous surface and encapsulate the biologically active agent. 2. The method of claim 1 wherein the porous exposed surface is a porous polymeric coating on a surface of the device. 3. The method of claim 2 wherein heating completely collapses the porous polymeric coating. 4. The method of claim 1 wherein the medical device is selected from the group consisting of stents, grafts, catheters, guide wires, heart valves, bone implants, spinal implants, covered stents, microspheres, and combinations thereof. 5. The method of claim 1 wherein the biologically active agent is a drug. 6. The method of claim 5 wherein the drug is selected from the group consisting of Plasmid DNA, genes, antisense oligonucleotides and other antisense agents, peptides, proteins, protein analogs, siRNA, shRNA, miRNA, ribozymes, DNAzymes and other DNA based agents, viral and non-viral vectors, lyposomes, cells, stem cells, antineoplastic agents, antiproliferative agents, antithrombogenic agents, anticoagulant agents, antiplatelet agents, antibiotics, anti-inflammatory agents, antimitotic agents, immunosuppressants, growth factors, cytokines, hormones, and combinations thereof. 7. A method of preparing a medical device comprising: coating a surface of a device with a porous polymeric coating; at least partially loading the porous polymeric coating with a biologically active agent; and heating at least the porous polymeric coating to at least partially collapse a surface of the porous polymeric coating and encapsulate the biologically active agent. 8. The method of claim 7 wherein heating completely collapses the porous polymeric coating. 9. The method of claim 7 wherein the medical device is selected from the group consisting of stents, grafts, catheters, guide wires, heart valves, bone implants, spinal implants, covered stents, microspheres, and combinations thereof. 10. The method of claim 7 wherein the biologically active agent is a drug. 11. The method of claim 10 wherein the drug is selected from the group consisting of Plasmid DNA, genes, antisense oligonucleotides and other antisense agents, peptides, proteins, protein analogs, siRNA, shRNA, miRNA, ribozymes, DNAzymes and other DNA based agents, viral and non-viral vectors, lyposomes, cells, stem cells, antineoplastic agents, antiproliferative agents, antithrombogenic agents, anticoagulant agents, antiplatelet agents, antibiotics, anti-inflammatory agents, antimitotic agents, immunosuppressants, growth factors, cytokines, hormones, and combinations thereof. 12. A method of preparing a medical device comprising: applying a coating composition comprising a polymer and a water soluble porogen to at least a portion of a surface of a device; removing at least a portion of the water soluble porogen to form a porous polymeric coating on at least a portion of the surface of the device; at least partially loading the porous polymeric coating with a biologically active agent; and heating at least the porous polymeric coating to at least partially collapse a surface of the porous polymeric coating and encapsulate the biologically active agent. 13. The method of claim 12 wherein the coating composition further comprises a solvent, and the method further includes removing at least a portion of the solvent during or after applying the coating composition. 14. The method of claim 12 wherein the polymer is selected from the group consisting of polycaprolactone (PCL), poly(lactide-co-glycolide) (PLGA), polyvinyl acetate (PVAC), polyvinyl alcohol, copolymers of PCL-PLGA, PLGA-polyethylene glycol (PEG), PCL-PEG, poly L-lactic acid (PLLA)-PEG, cellulose acetate, polyvinylidene chloride (PVDC), polyvinylidene fluoride, polymethyl acrylate, polyhexyl acrylate, polymethyl methacrylate, polyethyl methacrylate, polyhexyl methacrylate, polybutylene methyl acrylate (PBMA), and combinations thereof. 15. The method of claim 12 wherein the water soluble porogen is selected from the group consisting of citric acid, ascorbic acid, vitamin E, and combinations thereof. 16. The method of claim 12 wherein the medical device is selected from the group consisting of stents, grafts, catheters, guide wires, heart valves, bone implants, spinal implants, covered stents, microspheres, and combinations thereof. 17. The method of claim 12 wherein the biologically active agent is a drug. 18. The method of claim 17 wherein the drug is selected from the group consisting of Plasmid DNA, genes, antisense oligonucleotides and other antisense agents, peptides, proteins, protein analogs, siRNA, shRNA, miRNA, ribozymes, DNAzymes and other DNA based agents, viral and non-viral vectors, lyposomes, cells, stem cells, antineoplastic agents, antiproliferative agents, antithrombogenic agents, anticoagulant agents, antiplatelet agents, antibiotics, anti-inflammatory agents, antimitotic agents, immunosuppressants, growth factors, cytokines, hormones, and combinations thereof. 19. The method of claim 12 wherein heating comprises heating in air at a temperature of about 30° C. to about 100° C. 20. The method of claim 19 wherein heating comprises heating in air for about 30 seconds to about 60 minutes. 21. The method of claim 12 wherein heating completely collapses the porous polymeric coating. 22. A method of controlling the release rate of a biologically active agent from a polymeric coating, the method comprising: providing a device comprising an exposed surface comprising a porous polymeric coating, wherein at least a portion of the pores contain a biologically active agent; and heating at least the porous polymeric coating at a temperature of about 30° C. to about 100° C. to at least partially collapse a surface of the porous polymeric coating and encapsulate the biologically active agent to control the release rate of the biologically active agent from the exposed surface. 23. The method of claim 22 wherein heating completely collapses the porous polymeric coating. 24. The method of claim 22 wherein the device is selected from the group consisting of stents, grafts, catheters, guide wires, heart valves, bone implants, spinal implants, covered stents, microspheres, and combinations thereof. 25. The method of claim 22 wherein the biologically active agent is a drug. 26. The method of claim 25 wherein the drug is selected from the group consisting of Plasmid DNA, genes, antisense oligonucleotides and other antisense agents, peptides, proteins, protein analogs, siRNA, shRNA, miRNA, ribozymes, DNAzymes and other DNA based agents, viral and non-viral vectors, lyposomes, cells, stem cells, antineoplastic agents, antiproliferative agents, antithrombogenic agents, anticoagulant agents, antiplatelet agents, antibiotics, anti-inflammatory agents, antimitotic agents, immunosuppressants, growth factors, cytokines, hormones, and combinations thereof.